Profiling cytokines in peritoneal effluent through a targeted multiplex cytokine panel provides novel insight into the localized proinflammatory processes in patients undergoing peritoneal dialysis
- PMID: 39444816
- PMCID: PMC11496082
- DOI: 10.3389/fmed.2024.1463391
Profiling cytokines in peritoneal effluent through a targeted multiplex cytokine panel provides novel insight into the localized proinflammatory processes in patients undergoing peritoneal dialysis
Abstract
Objectives: The number of relevant markers indicating local intraperitoneal inflammation in patients undergoing peritoneal dialysis (PD) is limited. Therefore, this study aimed to evaluate the compatibility of peritoneal effluent (PE) for proteomic analysis and assess its potential utility in immunoprofiling studies.
Methods: This pilot study included six PD patients from the Peritoneal Dialysis Center, Department of Nephrology, Transplantology, and Internal Medicine in Szczecin, Poland. All patients were clinically stable, with no signs of infections or malignancy at the time of study. PE samples were collected during routine surveillance visits at the Peritoneal Dialysis Center. Proteomic analysis of the samples was conducted using the Olink® (Olink Proteomics AB, Uppsala, Sweden) Target 48 Cytokine panel.
Results: PE samples were successfully analyzed, with 28 out of 45 proteins found within the limit of quantitation (LOQ) and 32 out of 45 proteins detected above the limit of detection (LOD). No significant interference from the matrix was observed in the assay. Biomarkers associated with low-grade inflammation showed varied levels, and the observed patterns were comparable across all patients.
Conclusion: This study suggests that utilizing a cytokine panel with relative quantification is a promising method for PE immunoprofiling.
Keywords: IL6; chronic kidney disease; effluent; inflammation; peritoneal dialysis; proteomics.
Copyright © 2024 Okulewicz, Wojciuk, Wojciechowska-Koszko, Domański and Gołembiewska.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Peritoneal dialysis-related peritonitis in the years 2005-2007 among patients of the Peritoneal Dialysis Clinic of the Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University in Szczecin.Pol Arch Med Wewn. 2008 Dec;118(12):694-9. Pol Arch Med Wewn. 2008. PMID: 19202946
-
Osteoprotegerin and Inflammation in Incident Peritoneal Dialysis Patients.J Clin Med. 2024 Apr 18;13(8):2345. doi: 10.3390/jcm13082345. J Clin Med. 2024. PMID: 38673616 Free PMC article.
-
Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?Perit Dial Int. 2013 Sep-Oct;33(5):529-37. doi: 10.3747/pdi.2012.01063. Epub 2013 Sep 1. Perit Dial Int. 2013. PMID: 23994841 Free PMC article.
-
Proteomic Research in Peritoneal Dialysis.Int J Mol Sci. 2020 Jul 31;21(15):5489. doi: 10.3390/ijms21155489. Int J Mol Sci. 2020. PMID: 32752018 Free PMC article. Review.
-
[Peritoneal dialysis-related eosinophilic peritonitis: a case report and literature review].Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Aug 18;50(4):747-751. Beijing Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30122784 Review. Chinese.
References
LinkOut - more resources
Full Text Sources